Literature DB >> 8700506

Genetic change in actinic keratoses.

I Rehman1, M Takata, Y Y Wu, J L Rees.   

Abstract

Actinic keratoses (AKs) are small scaly red areas of skin characterised histologically by dysplasia, a minority of which are thought to be precursors of squamous cell carcinoma (SCC), and which show a high frequency of regression. Surprisingly, in view of their benign clinical course, they show a high frequency of loss of heterozygosity (LOH) with a median loss of four loci with almost 20% of lesions showing loss of eight or more alleles, as well as frequent p53 mutation. Loss was common on 3p (31%), 9p (39%), 9q (22%), 13q (52%), 17p (64%) and 17q (46%), and allele loss correlated with dysplasia. Topological disturbance of p21WAF1/CIP1 expression correlated with allele loss but was also seen together with increased wild-type p53 expression and an increase in the fraction of cycling cells in the absence of allele loss or p53 mutation, and is likely to represent an early change. P21WAF1/CIP1 expression appeared independent of p53 status. The frequency of LOH in AKs exceeded that of (invasive) SCCs suggesting that the relation between the accumulation of genetic change and behaviour for non-melanoma skin cancer is not straightforward.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700506

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes.

Authors:  Elias E Ayli; Susanne Dugas-Breit; Weijie Li; Christine Marshall; Liang Zhao; Marc Meulener; Thomas Griffin; Joel M Gelfand; John T Seykora
Journal:  Exp Dermatol       Date:  2010-04-20       Impact factor: 3.960

Review 2.  Sunlight and skin cancer: another link revealed.

Authors:  K H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 3.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

4.  Polo-like kinase 1 (Plk1) in non-melanoma skin cancers.

Authors:  Travis L Schmit; Weixiong Zhong; Minakshi Nihal; Nihal Ahmad
Journal:  Cell Cycle       Date:  2009-09-02       Impact factor: 4.534

5.  Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers.

Authors:  Nicola J Brown; Sue E Higham; Branko Perunovic; Mohammad Arafa; Sabapathy Balasubramanian; Ishtiaq Rehman
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 6.  Early cancers of the skin: clinical, histopathological, and molecular characteristics.

Authors:  Minoru Takata; Toshiaki Saida
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

7.  Genomic instability in human actinic keratosis and squamous cell carcinoma.

Authors:  Luciana Sanches Cabral; Cyro Festa Neto; José A Sanches; Itamar R G Ruiz
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers.

Authors:  M Takata; N Hatta; K Takehara
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.

Authors:  Liesbeth Hameetman; Suzan Commandeur; Jan Nico Bouwes Bavinck; Hermina C Wisgerhof; Frank R de Gruijl; Rein Willemze; Leon Mullenders; Cornelis P Tensen; Harry Vrieling
Journal:  BMC Cancer       Date:  2013-02-05       Impact factor: 4.430

10.  Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study.

Authors:  Pimentel Dr Neto; Mma Alchorne; Ns Michalany; Mamm Abreu; Rc Borra
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.